EVIDENCE-BASED MANAGEMENT OF HERB-DRUG INTERACTION IN CANCER CHEMOTHERAPY

被引:49
作者
Cheng, Chung-Wah [1 ]
Fan, Wing [1 ]
Ko, Seong-Gyu [2 ]
Song, Lisa [3 ]
Bian, Zhao-Xiang [1 ]
机构
[1] Hong Kong Baptist Univ, Sch Chinese Med, Kowloon Tong, Hong Kong, Peoples R China
[2] Kyung Hee Univ, Dept Prevent Med, Coll Korean Med, Seoul, South Korea
[3] Hong Kong Baptist Univ, Chinese Med Lib, Kowloon Tong, Hong Kong, Peoples R China
关键词
Chinese herbal medicine; cancer; chemotherapy; interaction; ALTERNATIVE MEDICINE USE; NATURAL HEALTH PRODUCTS; ST-JOHNS-WORT; CLINICAL-TRIALS; COMPLEMENTARY MEDICINE; UNITED-STATES; LUNG-CANCER; IN-VITRO; ONCOLOGY; CARE;
D O I
10.1016/j.explore.2010.06.004
中图分类号
R [医药、卫生];
学科分类号
100218 [急诊医学];
摘要
The fact that many cancer patients take herbal medicine, including Chinese herbal medicine, together with chemotherapy is well known. The potential for side effects resulting from concurrent use of these two different treatment modalities requires physicians to be aware of the potential risks and benefits that might arise. This study searched available evidence for herb-drug interaction in cancer therapy and identified 168 articles. Little direct evidence for such interaction could be found, whereas there is some indirect evidence for benefit. Hence, most of the concern about herb-drug interaction in chemotherapy appears to be theoretical. To resolve this discrepancy, evidence-based studies should be under-taken to document the positive and/or negative effects of the concomitant use of herbs with anticancer chemotherapeutic drugs. As evidence accumulates, it would be helpful to set up an internationally accessible database to document the use of Chinese medicine herbs with anticancer drugs. Once this information is collected, efforts should be made to educate health care professionals and patients about the use of Chinese herbal medicine together with Western drugs in treating cancer.
引用
收藏
页码:324 / 329
页数:6
相关论文
共 61 条
[1]
From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer [J].
Aggarwal, BB ;
Ichikawa, H ;
Garodia, P ;
Weerasinghe, P ;
Sethi, G ;
Bhatt, ID ;
Pandey, MK ;
Shishodia, S ;
Nair, MG .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2006, 10 (01) :87-118
[2]
ALFARO CL, 2001, PRINCIPALS CLIN PHAR, P167
[3]
Articles on complementary medicine in the mainstream medical literature - An investigation of MEDLINE, 1966 through 1996 [J].
Barnes, J ;
Abbot, NC ;
Harkness, EF ;
Ernst, E .
ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (15) :1721-1725
[4]
Drug interactions in oncology [J].
Beijnen, JH ;
Schellens, JHM .
LANCET ONCOLOGY, 2004, 5 (08) :489-496
[5]
Drug interactions in palliative care [J].
Bernard, SA ;
Bruera, E .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) :1780-1799
[6]
Block Keith I, 2002, Integr Cancer Ther, V1, P83, DOI 10.1177/1534735402001001007
[7]
Trends in complementary/alternative medicine use by breast cancer survivors: Comparing survey data from 1998 and 2005 [J].
Boon H.S. ;
Olatunde F. ;
Zick S.M. .
BMC Women's Health, 7 (1)
[8]
BOREK C, 2004, INTEGR CANC THER, V2, P333
[9]
Boullata Joseph, 2005, Nutr Clin Pract, V20, P33, DOI 10.1177/011542650502000133
[10]
Bruhn C, 2009, DEUT MED WOCHENSCHR, V134, P22